HLA-A and cancer: These findings were expanded by showing that the Vγ5Vδ1+TCR – which recognizes HLA-A*24:02 on cancer cells with a key role for CDR1 and CDR2 in MHC binding - is dependent on peptide loading of the HLA complex but not the presentation of a specific peptide (125).